343 related articles for article (PubMed ID: 9610707)
1. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
[TBL] [Abstract][Full Text] [Related]
3. The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.
Fowke JH; Motley SS; Barocas DA; Cookson MS; Concepcion R; Byerly S; Smith JA
Cancer Causes Control; 2011 Mar; 22(3):417-26. PubMed ID: 21170754
[TBL] [Abstract][Full Text] [Related]
4. Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report.
Pins MR; Fiadjoe JE; Korley F; Wong M; Rademaker AW; Jovanovic B; Yoo TK; Kozlowski JM; Raji A; Yang XJ; Lee C
Prostate Cancer Prostatic Dis; 2004; 7(3):243-8. PubMed ID: 15343364
[TBL] [Abstract][Full Text] [Related]
5. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection.
Simone NL; Remaley AT; Charboneau L; Petricoin EF; Glickman JW; Emmert-Buck MR; Fleisher TA; Liotta LA
Am J Pathol; 2000 Feb; 156(2):445-52. PubMed ID: 10666374
[TBL] [Abstract][Full Text] [Related]
6. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma.
Ghods R; Ghahremani MH; Madjd Z; Asgari M; Abolhasani M; Tavasoli S; Mahmoudi AR; Darzi M; Pasalar P; Jeddi-Tehrani M; Zarnani AH
Cancer Immunol Immunother; 2014 Dec; 63(12):1319-27. PubMed ID: 25186610
[TBL] [Abstract][Full Text] [Related]
7. Outlook of Gleason score in prostate carcinoma and correlation with PSA levels: A study in a tertiary care hospital.
Rani E; Nibhoria S; Nagpal N
J Cancer Res Ther; 2023; 19(5):1305-1310. PubMed ID: 37787299
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of finasteride: inhibition of disease progression and serum prostate-specific antigen reduction in patients with prostatic intraepithelial neoplasia.
He JW; Huang ZX; Wu JL; Su YF; Xu XL
Ann Biol Clin (Paris); 2024 Feb; 81(6):610-620. PubMed ID: 38391166
[TBL] [Abstract][Full Text] [Related]
9. Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer.
Doyle S; Feldman MD; Shih N; Tomaszewski J; Madabhushi A
BMC Bioinformatics; 2012 Oct; 13():282. PubMed ID: 23110677
[TBL] [Abstract][Full Text] [Related]
10. Primary signet ring cell carcinoma of prostate: A rare case report and review of literature.
Gupta M; Budhwar A; Prasad N; P Prasad SKS; Singh S
J Cancer Res Ther; 2023; 19(5):1075-1078. PubMed ID: 37787266
[TBL] [Abstract][Full Text] [Related]
11. Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis.
Li Q; Zhu J; Zhang Y; Pan Y; Li Z; Wang M; Gao Y; Feng D; He X; Zhang C
Sci Rep; 2023 Dec; 13(1):21629. PubMed ID: 38062230
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.
Mohsenzadegan M; Madjd Z; Asgari M; Abolhasani M; Shekarabi M; Taeb J; Shariftabrizi A
Cancer Immunol Immunother; 2013 Oct; 62(10):1609-18. PubMed ID: 23955683
[TBL] [Abstract][Full Text] [Related]
13. Utilization of NKX3.1, P501S, Prostate-Specific Antigen, and Steroidogenic Factor 1 to Distinguish Malignant Leydig Cell Tumor From Metastatic Prostatic Adenocarcinoma to the Testis.
Erak E; Ulbright TM; Epstein J
Arch Pathol Lab Med; 2023 Dec; 147(12):1458-1460. PubMed ID: 36881770
[TBL] [Abstract][Full Text] [Related]
14. Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells.
Limaye S; Chowdhury S; Rohatgi N; Ranade A; Syed N; Riedemann J; Patil D; Akolkar D; Datta V; Patel S; Chougule R; Shejwalkar P; Bendale K; Apurwa S; Schuster S; John J; Srinivasan A; Datar R
Cancer Med; 2023 Apr; 12(8):9116-9127. PubMed ID: 36718027
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer.
Russell PJ; Ow KT; Tam PN; Juarez J; Kingsley EA; Qu CF; Li Y; Cozzi PJ; Martiniello-Wilks R
Cancer Immunol Immunother; 2004 Nov; 53(11):995-1004. PubMed ID: 15449043
[TBL] [Abstract][Full Text] [Related]
16. Immunochemiluminescent detection of galectin-3 in tumoral tissue from prostate.
Araújo-Filho JL; Melo-Junior MR; Beltrão EI; de Lima LR; Antunes CB; de Carvalho LB
Int J Clin Exp Pathol; 2013; 6(9):1861-7. PubMed ID: 24040451
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and genetic ancestry are associated with apoptosis rates in benign and malignant prostatic epithelium.
Stinson J; McCall C; Dobbs RW; Mistry N; Rosenberg A; Nettey OS; Sharma P; Dixon M; Sweis J; Macias V; Sharifi R; Kittles RA; Kajdacsy-Balla A; Murphy AB
Prostate; 2023 Mar; 83(4):352-363. PubMed ID: 36479698
[TBL] [Abstract][Full Text] [Related]
18. Impact of Vasectomy on the Development and Progression of Prostate Cancer: Preclinical Evidence.
Kawahara T; Teramoto Y; Li Y; Ishiguro H; Gordetsky J; Yang Z; Miyamoto H
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824199
[TBL] [Abstract][Full Text] [Related]
19. The Correlations between the Intensity of Histopathological Ubiquitin-Specific Protease 11 Staining and Progression of Prostate Cancer.
Kim JH; Yang HJ; Lee KW; Park JJ; Lee CH; Jeon YS; Kim JH; Park S; Song SJ; Lee JH; Moon A; Kim YH; Song YS
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139829
[TBL] [Abstract][Full Text] [Related]
20. Patterns of B-cell lymphocyte expression changes in pre- and post-malignant prostate tissue are associated with prostate cancer progression.
Sadasivan SM; Loveless IM; Chen Y; Gupta NS; Sanii R; Bobbitt KR; Chitale DA; Williamson SR; Rundle AG; Rybicki BA
Cancer Med; 2024 Mar; 13(6):e7118. PubMed ID: 38523528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
